HUMAN PHARMACOKINETICS OF FTY 720
Neumayer Hh(Hochschule Hannover), Robert Schmouder(Novartis (United States)), Klemens Budde(Charité - Universitätsmedizin Berlin), R. Brunkhorst(Klinikum Region Hannover), P W Lücker(Boehringer Ingelheim (Germany)), Thomas U. Mayer(Max Planck Society), S Choudhury(Hochschule Hannover), Gerolf Kraus(Novartis (Switzerland))
Cited by 10
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|623
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2010|574